RT Journal Article
SR Electronic
T1 722 Evaluation of the effects of pembrolizumab alone and in combination(s) with MDSC-targeting agents MK-0482 and MK-4830 on the native cancer patient TME via functional spatial profiling (CIVO®)
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A817
OP A817
DO 10.1136/jitc-2023-SITC2023.0722
VO 11
IS Suppl 1
A1 Gundle, Kenneth
A1 Rajasekaran, Karthik
A1 Houlton, Jeffrey
A1 Clayburgh, Daniel
A1 Wagner, Michael
A1 Brinkmann, Elyse
A1 Nathan, Cherie-Ann
A1 Pang, John
A1 Zante, Annemieke Van
A1 Davis, Jessica
A1 Burns, Connor
A1 Frazier, Jason
A1 Beirne, Emily
A1 Merrell, Angela
A1 Mills, Bre
A1 Derry, Jonathan
A1 Sang, Hanrong
A1 Turner, Atticus
A1 Grenley, Marc
A1 Schauer, Nathan
A1 Jenkins, Wendy
A1 Klinghoffer, Richard
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A817.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.